Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.
about
Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelThe immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human AntibodiesComplete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gOA dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection.Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study.Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunityProduction of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.A CMV vaccine: TREATing despite the TRICKs.Cytomegalovirus infection in liver transplant recipients: updates on clinical managementCytomegalovirus Vaccines: Current Status and Future Prospects.Controlling Cytomegalovirus in the Age of Personalized Medicine.
P2860
Q27026924-2C2E365D-69A7-4703-830B-19B397585C99Q27692570-4BB5358D-5106-482E-9B3A-9C6B280700BFQ28550400-ACA3A1D0-D256-4587-8696-B1990BF163A8Q35214272-11F935DF-1B2B-42E2-AF1B-BADFF7A33954Q35886919-BAF1DD6C-FACC-4C80-AC36-E89FBFE37BECQ36281094-8725AB07-3381-4F8F-A31C-C8563D38E5A8Q36403590-7701D3B2-2039-4724-9D83-C6122D539C83Q36977623-5ACF8A57-DAA0-49E0-9037-5AC11E45DECDQ37409233-97CAD382-4740-488D-A397-88DAB3984B7EQ37523988-E5504673-E84A-41F6-9A08-A9935C89B9D7Q38242802-9FD8DBB9-9849-42B7-8DE5-E3AF4ECA3969Q38791353-125C77B3-BAE1-43EC-A45F-59710171E8B3Q48270925-F927C177-03CE-4913-9288-107E01F18EF2
P2860
Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Recent advances in designing a ...... -associated clinical diseases.
@ast
Recent advances in designing a ...... -associated clinical diseases.
@en
Recent advances in designing a ...... -associated clinical diseases.
@nl
type
label
Recent advances in designing a ...... -associated clinical diseases.
@ast
Recent advances in designing a ...... -associated clinical diseases.
@en
Recent advances in designing a ...... -associated clinical diseases.
@nl
prefLabel
Recent advances in designing a ...... -associated clinical diseases.
@ast
Recent advances in designing a ...... -associated clinical diseases.
@en
Recent advances in designing a ...... -associated clinical diseases.
@nl
P2093
P2860
P356
P1476
Recent advances in designing a ...... -associated clinical diseases.
@en
P2093
Corey Smith
Rajiv Khanna
Vijayendra Dasari
P2860
P304
P356
10.1586/ERV.13.46
P577
2013-06-01T00:00:00Z